Get started
Author

Sam Ness

ORCID: 0009-0006-6646-6948
Observed ORCID: 0009-0006-6646-6948
OpenAlex ID: A5043045055
Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al. · Molecular Cancer Therapeutics · 5
Abstract 909: Antibody fragment drug-conjugates (FDCs)-application of ANT-043 and ANT-045 in solid tumors
2021 · Mahendra P. Deonarain, Gokhan Yahioglu, et al. · Cancer Research · 3
Abstract 4399: ANT045: A novel format, antibody fragment drug-conjugate (FDC) product for challenging cMET-expressing solid tumors
2026 · Mahendra Deonarain, Bryan Edwards, et al. · Cancer Research
Abstract 2408: ADCs in cancer treatment: SPR-driven insights into discovery and characterization.
2026 · Soraya Diez-Posada, Cynthia Shuman, et al. · Cancer Research
Supplementary Figure 4 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Data from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Figure 1 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Figure 9 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Table 2 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Table 4 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Table 1 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Figure 2 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Figure 3 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Figure 7 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Figure 5 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Figure 10 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Table 3 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Figure 8 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Figure 6 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Table 5 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Data from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Abstract 1530: Gastric cancerantibody fragment drug-conjugates (FDCs): Applying a successful concept to solid tumours
2023 · Mahendra P. Deonarain, Gokhan Yahioglu, et al. · Cancer Research
Abstract 1763: Gastric cancer antibody fragment drug-conjugates (FDCs): Succeeding in solid tumors where ADCs fail
2022 · Mahendra P. Deonarain, Gokhan Yahioglu, et al. · Cancer Research
Works count: 23
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type